United Health Products, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.7M | $-2.0M | $-2.6M | $-1.7M | $-30.5M | $-15.7M | $-6.6M | $-5.4M |
| Depreciation & Amortization | $4.1K | $4.1K | $4.1K | $4.1K | $4.1K | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | $483.5K | $26.9M | $12.7M | $3.9M | $697.0K |
| Net Cash from Operating Activities | $-1.2M | $-1.2M | $-2.2M | $-619.7K | $-828.1K | $-1.3M | $-1.8M | $-1.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | $0 | $101.4K | $0 | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $-2.9K | $-40.5K | $0 | $-101.4K | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | $0 | $50.0K | — | — | — | — |
| Net Cash from Financing Activities | $1.1M | $1.3M | $2.3M | $651.8K | $803.8K | $1.5M | $1.8M | $1.1M |
| Net Change in Cash | — | — | — | — | — | $29.5K | $-14.6K | $-158.7K |
| Free Cash Flow | — | — | — | — | $-828.1K | $-1.4M | $-1.8M | — |